Suchergebnisse - "Lam, Carolyn S P"

PubPharm (34)

1

Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission : A Secondary Analysis of the STRONG-HF Randomized Clinical Trial

enthalten in: JAMA cardiology | 2024

von Cotter, G. | Deniau, B. | Davison, B. | +27

CommentOn: JAMA Cardiol. 2024 Feb 1;9(2):103-104. - PMID 38150243

2

Do we need dedicated heart failure with preserved ejection fraction clinics?

enthalten in: European heart journal | 2023

von Lam, C. | Ho, J.

CommentOn: Eur Heart J. 2023 May 1;44(17):1544-1556. - PMID 36924194

3

Kidney-Heart Connection : Implications of Chronic Kidney Disease for Screening and Prevention of Heart Failure

enthalten in: JACC. Heart failure | 2023

von Tuttle, K. | Lam, C.

CommentOn: JACC Heart Fail. 2023 May;11(5):523-537. - PMID 37052553

4

Machine Learning for Diastology and Heart Failure With Preserved Ejection Fraction : Hype or Hope?

enthalten in: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography | 2022

von Lam, C. | Ho, J.

CommentOn: J Am Soc Echocardiogr. 2022 Dec;35(12):1247-1255. - PMID 35753590

5

Sex, fat and the heart : it's all in the waist

enthalten in: European journal of heart failure | 2022

von Chandramouli, C. | Lam, C.

CommentOn: Eur J Heart Fail. 2021 Oct;23(10):1648-1658. - PMID 34053158

6

Reply : Assessing Pharmacologic Treatment Effect From a Meta-Analysis in Heart Failure

enthalten in: JACC. Heart failure | 2022

von Tromp, J. | Ouwerkerk, W. | Lam, C. | +1

CommentOn: JACC Heart Fail. 2022 Feb;10(2):73-84. - PMID 34895860

7

Response by Lam and Gerstein to Letter Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes : Exploratory Analysis of the AMPLITUDE-O Trial"

enthalten in: Circulation | 2022

von Lam, C. | Gerstein, H. | AMPLITUDE-O Investigators

CommentOn: Circulation. 2022 Jul 12;146(2):e5-e6. - PMID 35858158

8

Reply : A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of HFrEF

enthalten in: JACC. Heart failure | 2022

von Tromp, J. | Ouwerkerk, W. | Lam, C. | +1

CommentOn: JACC Heart Fail. 2022 Feb;10(2):73-84. - PMID 34895860

9

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced) : a post-hoc analysis of a randomised, double-blind trial

enthalten in: The lancet. Diabetes & endocrinology | 2022

von Verma, S. | Dhingra, N. | Butler, J. | +113

CommentOn: Lancet Diabetes Endocrinol. 2022 Jan;10(1):3-5. - PMID 34861151

10

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes : a systematic review and meta-analysis of randomised trials

enthalten in: The lancet. Diabetes & endocrinology | 2021

von Sattar, N. | Lee, M. | Kristensen, S. | +9

CommentOn: Lancet Diabetes Endocrinol. 2021 Oct;9(10):640-641. - PMID 34425084